USANA HEALTH SCIENCES INC (USNA) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US90328M1071
USANA HEALTH SCIENCES INC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 925.26 m USD |
| Gross profit | 724.41 m USD |
| Operating income | 37.43 m USD |
| EBIT | 39.24 m USD |
| Net income | 10.76 m USD |
| Diluted EPS – continuing operations | 0.58 USD |
Full history since 1994, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About USANA HEALTH SCIENCES INC
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
More stocks
- XINYUREN ORD A (SHH) EQSW Exp: (688573.SS)
- Asia Polymer Corp (1308.TW)
- Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570.KQ)
- LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)
- Caswell Inc (6416.TW)
- Jmicron Technology (4925.TWO)
- SC Asset Corporation Public Company Limited (SC.BK)
- OCTAVE SPECIALTY GROUP INC (OSG)
- Summarecon Agung Tbk (SMRA.JK)
- Teraplast Bist (TRP.RO)
- Innocare Optoelectronics Corp. (6861.TW)
- Kwangdong Phar (009290.KS)
Not investment advice. All data without warranty, price as of 02.11.2026. Details in the risk notice.